Lexicon Pharmaceuticals OverviewLexicon Pharmaceuticals Net Income
Profitability analysis for LXRX.
Quarterly Net Income
-$1.04M
↑ 95.88% YoY
As of Mar 2026
Annual Net Income (TTM)
-$26.09M
↑ 85.28% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...